Search results for "radium"

showing 7 items of 27 documents

Ra223 in bone metastases with osteolytic activity

2018

Radium 223 dichloride (Ra223) is the only targeted alpha therapy able to extend survival in patients with bone metastases from prostate cancer. Mechanism of action and data currently available focused mainly on osteoblastic metastases from prostate cancer. In our institution, a patient with breast cancer affected by osteolytic metastases was treated with off-label use of Ra223. The evaluation of the deposit areas of Ra223 showed a perfect overlap with the regions of osteolysis previously detected by scintigraphy, indicating a possible therapeutic effect. This case report is the first document attesting Ra223 deposit in osteolytic metastases opening new opportunity of therapeutic development…

Radium-223lcsh:Medical physics. Medical radiology. Nuclear medicinemedicine.medical_specialtyOsteolysislcsh:R895-920Case ReportScintigraphy030218 nuclear medicine & medical imagingradium 22303 medical and health sciencesProstate cancer0302 clinical medicineBreast cancerbreast cancerosteoblastic bone metastasesmedicineIn patientRadium-223 Dichlorideosteolytic bone metastasesmedicine.diagnostic_testbusiness.industryBone metastasesTherapeutic effectmedicine.disease030220 oncology & carcinogenesisRadiologybusinessmedicine.drugWorld Journal of Nuclear Medicine
researchProduct

Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience

2019

Background: Treatment with radium-223 has been shown to increase survival and to delay skeletal events related to bone metastases of patients with metastatic Castration Resistant Prostate Cancer (mCRPC). This treatment has also proved to be well tolerated, and hematological toxicity, in particular anemia, represents the most represented adverse event. Materials and methods: We evaluated the hematologic toxicity of Ra-223 treatment in a real-life experience of 38 patients from two Italian cancer centers, with bone metastases from mCRPC. The main endpoint of the study was the evaluation of the efficacy and tolerability of treatment with radium-223, with greater reference to hematological toxi…

Radium-223medicine.medical_specialtyAnemiaUrology030232 urology & nephrologyNeutropenialcsh:RC870-923Ra-22303 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinemedicineAdverse effectCancerToxicitybusiness.industryProstatemedicine.diseaselcsh:Diseases of the genitourinary system. UrologyDiscontinuationOlderTolerabilityDocetaxel030220 oncology & carcinogenesisOriginal Articlebusinessmedicine.drugProstate International
researchProduct

Isotope Shifts of Radium Monofluoride Molecules

2021

Isotope shifts of $^{223-226,228}$Ra$^{19}$F were measured for different vibrational levels in the electronic transition $A^{2}{}{\Pi}_{1/2}\leftarrow X^{2}{}{\Sigma}^{+}$. The observed isotope shifts demonstrate the particularly high sensitivity of radium monofluoride to nuclear size effects, offering a stringent test of models describing the electronic density within the radium nucleus. Ab initio quantum chemical calculations are in excellent agreement with experimental observations. These results highlight some of the unique opportunities that short-lived molecules could offer in nuclear structure and in fundamental symmetry studies.

[PHYS.NUCL] Physics [physics]/Nuclear Theory [nucl-th]FIELD SHIFTNuclear TheoryAtomic Physics (physics.atom-ph)Ab initioGeneral Physics and AstronomyNUCLEAR-STRUCTUREnucl-ex01 natural sciencesPhysics - Atomic Physics010305 fluids & plasmasENERGYchemistry.chemical_compoundatomifysiikkaMOMENTSPhysics::Atomic PhysicsNuclear Experiment (nucl-ex)Nuclear ExperimentNuclear ExperimentPhysicsIsotopePhysicsNuclear structureradiumNuclear Physics - TheoryPhysical SciencesAtomic physicsydinfysiikkanucl-th[PHYS.NUCL]Physics [physics]/Nuclear Theory [nucl-th]Monofluoride[PHYS.NEXP] Physics [physics]/Nuclear Experiment [nucl-ex][PHYS.PHYS.PHYS-GEN-PH] Physics [physics]/Physics [physics]/General Physics [physics.gen-ph]Physics MultidisciplinaryOther Fields of PhysicsFOS: Physical sciences[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]physics.atom-phMolecular electronic transitionELECTRONIC-STRUCTURE CALCULATIONSNuclear Theory (nucl-th)ATOMS0103 physical sciencesMoleculeSPECTRANuclear Physics - ExperimentSensitivity (control systems)010306 general physicsisotoopitScience & Technology[PHYS.PHYS.PHYS-GEN-PH]Physics [physics]/Physics [physics]/General Physics [physics.gen-ph]chemistryMECHANICSMASS DEPENDENCELASERElectronic density
researchProduct

Can radium 223 be a conservative non-surgical management of medication-related osteonecrosis of the jaw?

2019

AbstractOsteonecrosis of the jaw (ONJ) is a rare and severe necrotic bone disease reflecting a compromise in the body's osseous healing mechanisms and unique to the craniofacial region. Radium 223 dichloride (Ra223) is the only targeted alpha therapy able to extend survival in patients with bone metastases from prostate cancer. Mechanism of action and data currently available focused mainly on osteoblastic metastases from prostate cancer. In 2018, a Caucasian 54-year-old woman presented to our institution for a breast cancer with bone metastases. Since the patient refused any treatment and taking into account the bone disease, our multidisciplinary team evaluated a supplementary strategy wi…

lcsh:Medical physics. Medical radiology. Nuclear medicineRadium-223medicine.medical_specialtyBone diseaselcsh:R895-920Case Report030218 nuclear medicine & medical imagingradium 22303 medical and health sciencesProstate cancerbreast cancer0302 clinical medicineBreast cancermedicineCraniofacialProspective cohort studybusiness.industryBone metastasesCancermedicine.diseaseSurgeryBone metastaseosteonecrosis of the jaw030220 oncology & carcinogenesisbusinessOsteonecrosis of the jawmedicine.drugWorld Journal of Nuclear Medicine
researchProduct

Dosimetric characterization of two radium sources for retrospective dosimetry studies

2015

Purpose: During the first part of the 20th century, Ra-226 was the most used radionuclide for brachytherapy. Retrospective accurate dosimetry, coupled with patient follow up, is important for advan ...

medicine.medical_specialtyPatient follow upbusiness.industrymedicine.medical_treatmentBrachytherapychemistry.chemical_elementGeneral MedicineRadiation therapyRadiumchemistryMedicineDosimetryMedical physicsbusinessNuclear medicineDose rateMedical Physics
researchProduct

Identification of the Jπ = 1− state in 218Ra populated via α decay of 222Th

2016

The α decay of 222Th populating the low-lying J π = 3− state, and also a proposed 1− state, in 218Ra has been observed. The observations suggest an excitation energy of 853 keV for the 1− state, which is 60 keV above the 3− state. The hindrance factors of these α decays give a possible boundary to the region of ground-state octupole deformation in the light-actinide nuclei. The relative positions of the J π = 1− and 3− states suggest they are produced by an octupole-vibrational mechanism, as opposed to α clustering or rotations of a reflection-asymmetric octupole-deformed shape. peerReviewed

radiumNuclear Theoryoctupole correlationsdeformed nucleitoriumexcited states
researchProduct

Spectroscopy of short-lived radioactive molecules

2020

Molecular spectroscopy offers opportunities for the exploration of the fundamental laws of nature and the search for new particle physics beyond the standard model1–4. Radioactive molecules—in which one or more of the atoms possesses a radioactive nucleus—can contain heavy and deformed nuclei, offering high sensitivity for investigating parity- and time-reversal-violation effects5,6. Radium monofluoride, RaF, is of particular interest because it is predicted to have an electronic structure appropriate for laser cooling6, thus paving the way for its use in high-precision spectroscopic studies. Furthermore, the effects of symmetry-violating nuclear moments are strongly enhanced5,7–9 in molecu…

spektroskopiacollinearnucl-ex01 natural sciences010305 fluids & plasmasRadiumchemistry.chemical_compoundIonizationExperimental nuclear physicsNuclear ExperimentPhysicsMultidisciplinaryLarge Hadron ColliderStable isotope rationew physics[PHYS.HTHE]Physics [physics]/High Energy Physics - Theory [hep-th]hep-thmolekyylithep-phradiumelectron: electric momentNuclear Physics - Theoryradioactivitymany-body problemElectronic structure of atoms and moleculesAtomic physicsydinfysiikkaParticle Physics - Theoryexceptionalnucl-th[PHYS.NUCL]Physics [physics]/Nuclear Theory [nucl-th]MonofluorideResearchInstitutes_Networks_Beacons/photon_science_institutechemistry.chemical_elementnucleus: structure functionElectronic structure[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]Photon Science InstituteArticle0103 physical sciencesionizationMoleculeNuclear Physics - Experiment010306 general physicsSpectroscopyenhancementParticle Physics - Phenomenologystabilitysensitivitylaserchemistry[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]Exotic atoms and moleculesnucleus: deformation
researchProduct